Hepatocellular carcinoma and direct-acting antivirals: A never ending story?
作者信息
Calvaruso Vincenza, Craxì Antonio
机构信息
Gastroenterologia & Epatologia, DIBIMIS, University di Palermo, Palermo, Italy.
出版信息
Liver Int. 2017 Jun;37(6):812-814. doi: 10.1111/liv.13421.
PMID:28544693
Abstract
摘要
相似文献
1
Hepatocellular carcinoma and direct-acting antivirals: A never ending story?肝细胞癌与直接作用抗病毒药物：一个永无止境的故事？
Liver Int. 2017 Jun;37(6):812-814. doi: 10.1111/liv.13421.
2
Damned if you do, damned if you don't: The evolving story of de novo and recurrent hepatocellular carcinoma amongst those treated with direct-acting antivirals for hepatitis C virus.做也该死，不做也该死：丙型肝炎病毒直接抗病毒治疗患者中初发和复发性肝细胞癌的演变故事。
Liver Int. 2017 Jun;37(6):809-811. doi: 10.1111/liv.13422.
3
Con: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinoma.反对观点：使用直接抗病毒药物治疗丙型肝炎病毒：无需担忧肝细胞癌的潜在威胁。
Liver Transpl. 2017 Dec;23(12):1596-1600. doi: 10.1002/lt.24959.
4
Pro: Direct-acting antivirals are associated with occurrence and recurrence of hepatocellular carcinoma.专业观点：直接作用抗病毒药物与肝细胞癌的发生和复发有关。
Liver Transpl. 2017 Dec;23(12):1593-1595. doi: 10.1002/lt.24960.
5
Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis.抗病毒治疗对慢性病毒性肝炎患者肝细胞癌风险的影响。
Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1277-1282. doi: 10.1097/MEG.0000000000001254.
6
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.直接作用抗病毒药物与慢性丙型肝炎相关肝细胞癌：喜忧参半。
World J Gastroenterol. 2018 Jun 28;24(24):2582-2595. doi: 10.3748/wjg.v24.i24.2582.
7
De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.丙型肝炎病毒直接抗病毒治疗后的初发与复发性肝细胞癌
Eur J Gastroenterol Hepatol. 2018 Jan;30(1):39-43. doi: 10.1097/MEG.0000000000001004.
8
Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma.丙型肝炎病毒感染对肝细胞癌的影响
Gastroenterol Clin North Am. 2015 Dec;44(4):761-73. doi: 10.1016/j.gtc.2015.07.005. Epub 2015 Aug 12.
9
Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients.直接抗病毒药物治疗丙型肝炎后肝细胞癌的肿瘤行为：与非直接抗病毒药物治疗患者的比较分析
Eur J Gastroenterol Hepatol. 2019 Jan;31(1):75-79. doi: 10.1097/MEG.0000000000001264.
10
De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.直接作用抗病毒药物时代肝移植受者中的原发性肝细胞癌。
Hepatology. 2018 Oct;68(4):1288-1297. doi: 10.1002/hep.30045.
引用本文的文献
1
Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals.循环白细胞介素-13与接受直接作用抗病毒药物治疗的丙型肝炎病毒感染患者新发肝癌有关。
Cancers (Basel). 2020 Dec 18;12(12):3820. doi: 10.3390/cancers12123820.
Zotero 插件